BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26493727)

  • 1. DNA damage-induced apoptosis suppressor (DDIAS), a novel target of NFATc1, is associated with cisplatin resistance in lung cancer.
    Im JY; Lee KW; Won KJ; Kim BK; Ban HS; Yoon SH; Lee YJ; Kim YJ; Song KB; Won M
    Biochim Biophys Acta; 2016 Jan; 1863(1):40-9. PubMed ID: 26493727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells.
    Won KJ; Im JY; Kim BK; Ban HS; Jung YJ; Jung KE; Won M
    Cell Death Dis; 2017 Jan; 8(1):e2554. PubMed ID: 28079882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFATc1 regulates the transcription of DNA damage-induced apoptosis suppressor.
    Im JY; Lee KW; Won KJ; Kim BK; Ban HS; Yoon SH; Lee YJ; Kim YJ; Song KB; Won M
    Data Brief; 2015 Dec; 5():975-80. PubMed ID: 26740967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathway.
    Im JY; Kim BK; Yoon SH; Cho BC; Baek YM; Kang MJ; Kim N; Gong YD; Won M
    Exp Mol Med; 2021 Apr; 53(4):643-653. PubMed ID: 33859351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes β-catenin-mediated invasion.
    Im JY; Yoon SH; Kim BK; Ban HS; Won KJ; Chung KS; Jung KE; Won M
    Biochim Biophys Acta; 2016 Nov; 1859(11):1449-1458. PubMed ID: 27412911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.
    Im JY; Kim BK; Lee JY; Park SH; Ban HS; Jung KE; Won M
    Oncogene; 2018 Mar; 37(9):1251-1262. PubMed ID: 29242605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Noxin is an anti-apoptotic protein in response to DNA damage of A549 non-small cell lung carcinoma.
    Won KJ; Im JY; Yun CO; Chung KS; Kim YJ; Lee JS; Jung YJ; Kim BK; Song KB; Kim YH; Chun HK; Jung KE; Kim MH; Won M
    Int J Cancer; 2014 Jun; 134(11):2595-604. PubMed ID: 24214091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion.
    Kawahara T; Kashiwagi E; Ide H; Li Y; Zheng Y; Ishiguro H; Miyamoto H
    Prostate; 2015 May; 75(6):573-84. PubMed ID: 25631176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells.
    Ueda K; Kawashima H; Ohtani S; Deng WG; Ravoori M; Bankson J; Gao B; Girard L; Minna JD; Roth JA; Kundra V; Ji L
    Cancer Res; 2006 Oct; 66(19):9682-90. PubMed ID: 17018626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miconazole inhibits signal transducer and activator of transcription 3 signaling by preventing its interaction with DNA damage-induced apoptosis suppressor.
    Yoon SH; Kim BK; Kang MJ; Im JY; Won M
    Cancer Sci; 2020 Jul; 111(7):2499-2507. PubMed ID: 32476221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data on the transcriptional regulation of DNA damage induced apoptosis suppressor (DDIAS) by ERK5/MEF2B pathway in lung cancer cells.
    Im JY; Yoon SH; Kim BK; Ban HS; Won KJ; Chung KS; Jung KE; Won M
    Data Brief; 2016 Dec; 9():257-61. PubMed ID: 27660814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
    Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
    Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
    Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
    Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
    Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
    Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GMI, an Immunomodulatory Protein from Ganoderma microsporum, Potentiates Cisplatin-Induced Apoptosis via Autophagy in Lung Cancer Cells.
    Hsin IL; Ou CC; Wu MF; Jan MS; Hsiao YM; Lin CH; Ko JL
    Mol Pharm; 2015 May; 12(5):1534-43. PubMed ID: 25811903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer.
    Im JY; Kang MJ; Kim BK; Won M
    Exp Mol Med; 2023 May; 55(5):879-885. PubMed ID: 37121974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
    Crotti TN; Flannery M; Walsh NC; Fleming JD; Goldring SR; McHugh KP
    Gene; 2006 May; 372():92-102. PubMed ID: 16513293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.